Lorene Silva

Dr. Lorene Silva


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
LSLorene Silva
Lorene Silva
ACAmabel Fernandes Correia
Amabel Fernandes Correia
Joao Victor Dutra GomesJoao Victor Dutra Gomes
Joao Victor Dutra Gomes
WRWanderson Romão
Wanderson Romão
LMLarissa Campos Motta
Larissa Campos Motta
YBYris Maria Fonseca Bazzo
Yris Maria Fonseca Bazzo
Candida species are the main fungal agents causing infectious conditions in hospital patients. The development of new drugs with antifungal potential, increased efficacy, and reduced toxicity is essential to face the challenge of fungal resistance to standard treatments. The aim of this study is to evaluate the in vitro antifungal effects of two crude extracts of Crinum americanum L., a rich alkaloid fraction and lycorine alkaloid, on the Candida species. As such, we used a disk diffusion susceptibility test, determined the minimum inhibitory concentration (MIC), and characterized the components of the extracts using Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry (ESI FT-ICR MS). The extracts were found to have antifungal activity against various Candida species. The chemical characterization of the extracts indicated the presence of alkaloids such as lycorine and crinine. The Amaryllidaceae family has a promising antifungal potential. Furthermore, it was found that the alkaloid lycorine directly contributes to the effects that were observed for the extracts and fraction of C. americanum.